Solution structure of kistrin, a potent platelet aggregation inhibitor and GP IIb-IIIa antagonist.

PubWeight™: 1.48‹?› | Rank: Top 4%

🔗 View Article (PMID 1862345)

Published in Science on July 26, 1991

Authors

M Adler1, R A Lazarus, M S Dennis, G Wagner

Author Affiliations

1: Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115.

Articles citing this

RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway. Proc Natl Acad Sci U S A (1994) 2.49

Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization. EMBO J (1997) 1.82

Structure of adenovirus complexed with its internalization receptor, alphavbeta5 integrin. J Virol (1999) 1.57

Identification of a binding site in the disintegrin domain of fertilin required for sperm-egg fusion. Proc Natl Acad Sci U S A (1994) 1.48

The precursor region of a protein active in sperm-egg fusion contains a metalloprotease and a disintegrin domain: structural, functional, and evolutionary implications. Proc Natl Acad Sci U S A (1993) 1.45

A role for the disintegrin domain of cyritestin, a sperm surface protein belonging to the ADAM family, in mouse sperm-egg plasma membrane adhesion and fusion. J Cell Biol (1997) 1.33

Primary megakaryocytes reveal a role for transcription factor NF-E2 in integrin alpha IIb beta 3 signaling. J Cell Biol (1999) 1.12

Snake venom disintegrins: novel dimeric disintegrins and structural diversification by disulphide bond engineering. Biochem J (2003) 1.10

High-affinity self-reactive human antibodies by design and selection: targeting the integrin ligand binding site. Proc Natl Acad Sci U S A (1993) 1.06

Echistatin disulfide bridges: selective reduction and linkage assignment. Protein Sci (1993) 0.99

Expression of conformationally constrained adhesion peptide in an antibody CDR loop and inhibition of natural killer cell cytotoxic activity by an antibody antigenized with the RGD motif. EMBO J (1993) 0.96

Crystallographic study of the structure of colipase and of the interaction with pancreatic lipase. Protein Sci (1995) 0.96

ADAM disintegrin-like domain recognition by the lymphocyte integrins alpha4beta1 and alpha4beta7. Biochem J (2005) 0.91

Molecular cloning and expression of catrocollastatin, a snake-venom protein from Crotalus atrox (western diamondback rattlesnake) which inhibits platelet adhesion to collagen. Biochem J (1995) 0.88

Disulphide-bond pattern and molecular modelling of the dimeric disintegrin EMF-10, a potent and selective integrin alpha5beta1 antagonist from Eristocophis macmahoni venom. Biochem J (2000) 0.87

An echistatin C-terminal peptide activates GPIIbIIIa binding to fibrinogen, fibronectin, vitronectin and collagen type I and type IV. Biochem J (1993) 0.85

ADM-1, a protein with metalloprotease- and disintegrin-like domains, is expressed in syncytial organs, sperm, and sheath cells of sensory organs in Caenorhabditis elegans. Mol Biol Cell (1996) 0.84

The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD. Biochem J (1995) 0.83

Simultaneous determination of disulphide bridge topology and three-dimensional structure using ambiguous intersulphur distance restraints: possibilities and limitations. J Biomol NMR (2000) 0.83

Positional importance of Pro53 adjacent to the Arg49-Gly50-Asp51 sequence of rhodostomin in binding to integrin alphaIIbbeta3. Biochem J (2001) 0.83

Conformation and concerted dynamics of the integrin-binding site and the C-terminal region of echistatin revealed by homonuclear NMR. Biochem J (2005) 0.83

The disulfide bond pattern of catrocollastatin C, a disintegrin-like/cysteine-rich protein isolated from Crotalus atrox venom. Protein Sci (2000) 0.82

Amino acid sequence and homology modeling of obtustatin, a novel non-RGD-containing short disintegrin isolated from the venom of Vipera lebetina obtusa. Protein Sci (2003) 0.82

Structure and expression of GSL1 and GSL2 genes encoding gibberellin stimulated-like proteins in diploid and highly heterozygous tetraploid potato reveals their highly conserved and essential status. BMC Genomics (2014) 0.80

Structure of acostatin, a dimeric disintegrin from Southern copperhead (Agkistrodon contortrix contortrix), at 1.7 A resolution. Acta Crystallogr D Biol Crystallogr (2008) 0.79

Proteolytic degradation of the RGD-binding and non-RGD-binding conformers of human platelet integrin glycoprotein IIb/IIIa: clues for identification of regions involved in the receptor's activation. Biochem J (1994) 0.78

Structure and function of snake venom proteins affecting platelet plug formation. Toxins (Basel) (2009) 0.78

Evaluation of the role of proline residues flanking the RGD motif of dendroaspin, an inhibitior of platelet aggregation and cell adhesion. Biochem J (2001) 0.77

ADAM-15 disintegrin-like domain structure and function. Toxins (Basel) (2010) 0.76

Amino acid sequence and molecular modelling of glycoprotein IIb-IIIa and fibronectin receptor iso-antagonists from Trimeresurus elegans venom. Biochem J (1996) 0.76

Structural analysis of the KGD sequence loop of barbourin, an alphaIIbbeta3-specific disintegrin. J Comput Aided Mol Des (2000) 0.76

Recombinant decorsin: dynamics of the RGD recognition site. Protein Sci (2000) 0.75

Metalloproteases Affecting Blood Coagulation, Fibrinolysis and Platelet Aggregation from Snake Venoms: Definition and Nomenclature of Interaction Sites. Toxins (Basel) (2016) 0.75

Articles by these authors

(truncated to the top 100)

The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology (1997) 13.27

Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet (2004) 7.33

Improved spectral resolution in cosy 1H NMR spectra of proteins via double quantum filtering. Biochem Biophys Res Commun (1983) 7.26

Utilization of site-directed spin labeling and high-resolution heteronuclear nuclear magnetic resonance for global fold determination of large proteins with limited nuclear overhauser effect data. Biochemistry (2000) 4.52

Canalization in evolutionary genetics: a stabilizing theory? Bioessays (2000) 3.62

Conformation and function of the N-linked glycan in the adhesion domain of human CD2. Science (1995) 3.62

Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke (2003) 3.58

Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol (2000) 3.39

Very early risk of stroke after a first transient ischemic attack. Stroke (2003) 3.26

The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science (1999) 3.23

Structure of translation factor eIF4E bound to m7GDP and interaction with 4E-binding protein. Nat Struct Biol (1997) 3.14

Sequential resonance assignments as a basis for determination of spatial protein structures by high resolution proton nuclear magnetic resonance. J Mol Biol (1982) 3.05

Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL. Nat Cell Biol (2001) 3.03

NMR spectroscopy: a multifaceted approach to macromolecular structure. Q Rev Biophys (2000) 2.98

Effect of correcting outcome data for case mix: an example from stroke medicine. BMJ (1996) 2.79

How well does the Oxfordshire community stroke project classification predict the site and size of the infarct on brain imaging? J Neurol Neurosurg Psychiatry (2000) 2.72

Improved resolution in triple-resonance spectra by nonlinear sampling in the constant-time domain. J Biomol NMR (1994) 2.72

Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell (1999) 2.58

Intramolecular masking of nuclear import signal on NF-AT4 by casein kinase I and MEKK1. Cell (1998) 2.57

Physiology of penile erection. Physiol Rev (1995) 2.57

Structure of the Mad2 spindle assembly checkpoint protein and its interaction with Cdc20. Nat Struct Biol (2000) 2.49

Reduced pulmonary function in patients with spinal osteoporotic fractures. Osteoporos Int (1998) 2.45

Amide protein exchange and surface conformation of the basic pancreatic trypsin inhibitor in solution. Studies with two-dimensional nuclear magnetic resonance. J Mol Biol (1982) 2.44

The solution structure of eglin c based on measurements of many NOEs and coupling constants and its comparison with X-ray structures. Protein Sci (1992) 2.25

The eIF1A solution structure reveals a large RNA-binding surface important for scanning function. Mol Cell (2000) 2.24

Structure and interactions of the translation initiation factor eIF1. EMBO J (1999) 2.24

Complications after acute stroke. Stroke (1996) 2.21

A randomised comparison of the EuroQol and Short Form-36 after stroke. United Kingdom collaborators in the International Stroke Trial. BMJ (1997) 2.20

MR diffusion-weighted imaging and outcome prediction after ischemic stroke. Neurology (2006) 2.19

An optimized 3D NOESY-HSQC. J Magn Reson B (1996) 2.17

In vitro studies with combinations of 5-fluorocytosine and amphotericin B. Antimicrob Agents Chemother (1975) 2.10

Clinical case definitions for malaria: clinical malaria associated with very low parasite densities in African infants. Trans R Soc Trop Med Hyg (1999) 2.08

Investigation of protein motions via relaxation measurements. Methods Enzymol (1994) 2.05

Fractal analysis of retinal vessels suggests that a distinct vasculopathy causes lacunar stroke. Neurology (2010) 2.04

Incidence and outcomes of respiratory viral infections in lung transplant recipients: a prospective study. Thorax (2013) 2.02

Sequential resonance assignments in protein 1H nuclear magnetic resonance spectra. Basic pancreatic trypsin inhibitor. J Mol Biol (1982) 2.01

A solubility-enhancement tag (SET) for NMR studies of poorly behaving proteins. J Biomol NMR (2001) 1.98

Complete DNA sequence of yeast chromosome II. EMBO J (1994) 1.97

Mapping of the spectral densities of N-H bond motions in eglin c using heteronuclear relaxation experiments. Biochemistry (1992) 1.91

Mechanisms contributing to T cell receptor signaling and assembly revealed by the solution structure of an ectodomain fragment of the CD3 epsilon gamma heterodimer. Cell (2001) 1.87

Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment. Cell (1998) 1.87

New method for susceptibility testing with antifungal agents. Antimicrob Agents Chemother (1975) 1.83

In vitro and in vivo studies with BL-S786, cefoxitin, and cefamandole. Antimicrob Agents Chemother (1978) 1.82

Solution structure of the DNA-binding domain of Cd2-GAL4 from S. cerevisiae. Nature (1992) 1.79

Peptide exosite inhibitors of factor VIIa as anticoagulants. Nature (2000) 1.77

Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counterreceptors. Cell (1999) 1.75

Dynamics of the aromatic amino acid residues in the globular conformation of the basic pancreatic trypsin inhibitor (BPTI). I. 1H NMR studies. Biophys Struct Mech (1976) 1.75

Is visible infarction on computed tomography associated with an adverse prognosis in acute ischemic stroke? Stroke (1998) 1.72

Can simple clinical features be used to identify patients with severe carotid stenosis on Doppler ultrasound? J Neurol Neurosurg Psychiatry (1999) 1.71

Severe and uncommon involuntary movement disorders due to psychotropic drugs. Pharmacopsychiatry (2004) 1.63

European soil sampling guidelines for soil pollution studies. Sci Total Environ (2001) 1.63

Characterization of the distribution of internal motions in the basic pancreatic trypsin inhibitor using a large number of internal NMR probes. Q Rev Biophys (1983) 1.61

Resolution and sensitivity of high field nuclear magnetic resonance spectroscopy. J Biomol NMR (2004) 1.60

In vitro activities of five oral cephalosporins against aerobic pathogenic bacteria. Antimicrob Agents Chemother (1977) 1.60

Platelet glycoprotein IIb-IIIa protein antagonists from snake venoms: evidence for a family of platelet-aggregation inhibitors. Proc Natl Acad Sci U S A (1990) 1.55

Sleep-disordered breathing after stroke: a randomised controlled trial of continuous positive airway pressure. J Neurol Neurosurg Psychiatry (2006) 1.55

Systematic application of high-resolution, phase-sensitive two-dimensional 1H-NMR techniques for the identification of the amino-acid-proton spin systems in proteins. Rabbit metallothionein-2. Eur J Biochem (1985) 1.54

Intimacy and sexual risk behaviour in serodiscordant male couples. AIDS Care (1995) 1.54

A novel application of nuclear Overhauser enhancement (NOE) in proteins: analysis of correlated events in the exchange of internal labile protons. Biochem Biophys Res Commun (1980) 1.54

Interobserver reliability of a clinical classification of acute cerebral infarction. Stroke (1993) 1.54

Solution structure of the CIDE-N domain of CIDE-B and a model for CIDE-N/CIDE-N interactions in the DNA fragmentation pathway of apoptosis. Cell (1999) 1.50

SH3 domain recognition of a proline-independent tyrosine-based RKxxYxxY motif in immune cell adaptor SKAP55. EMBO J (2000) 1.50

Tampon-induced changes in vaginal oxygen and carbon dioxide tensions. Am J Obstet Gynecol (1984) 1.46

Cloning and sequencing of the xylose isomerase and xylulose kinase genes of Escherichia coli. Appl Environ Microbiol (1984) 1.45

Three-dimensional structure of rabbit liver [Cd7]metallothionein-2a in aqueous solution determined by nuclear magnetic resonance. J Mol Biol (1988) 1.45

4E binding proteins inhibit the translation factor eIF4E without folded structure. Biochemistry (1998) 1.45

Unusual Rel-like architecture in the DNA-binding domain of the transcription factor NFATc. Nature (1997) 1.43

The influence of randomized trials on the use of anticoagulants for atrial fibrillation. Age Ageing (1999) 1.42

Brain choline concentration. Early quantitative marker of ischemia and infarct expansion? Neurology (2010) 1.42

Application of nonlinear sampling schemes to COSY-type spectra. J Biomol NMR (1993) 1.41

[Morphologic studies of the placentas of HIV-positive mothers]. Pathologe (1988) 1.41

Quantification of maximum-entropy spectrum reconstructions. J Magn Reson (1997) 1.40

Differential effects of first antiepileptic drug application on cognition in lesional and non-lesional patients with epilepsy. Seizure (1993) 1.40

Individual amide proton exchange rates in thermally unfolded basic pancreatic trypsin inhibitor. Biochemistry (1985) 1.39

Preparing the veterinary profession for corporate and trade issues in the Americas: proceedings of a conference on synergism and globalization, Santiago, Chile, May 6-8, 2001. J Vet Med Educ (2001) 1.38

Solution structure of Apaf-1 CARD and its interaction with caspase-9 CARD: a structural basis for specific adaptor/caspase interaction. Proc Natl Acad Sci U S A (1999) 1.38

Do acute diffusion- and perfusion-weighted MRI lesions identify final infarct volume in ischemic stroke? Stroke (2005) 1.36

The need for invasive cardiological assessment and operation: viewpoint of a district general hospital. Br Heart J (1986) 1.36

Internal mobility in the partially folded DNA binding and dimerization domains of GAL4: NMR analysis of the N-H spectral density functions. Biochemistry (1996) 1.35

Negative attitudes among short-term stroke survivors predict worse long-term survival. Stroke (2001) 1.34

Potassium uniport and ATP synthesis in Halobacterium halobium. Eur J Biochem (1978) 1.34

Structure, specificity and CDR mobility of a class II restricted single-chain T-cell receptor. Nat Struct Biol (1999) 1.32

Hox cluster genomics in the horn shark, Heterodontus francisci. Proc Natl Acad Sci U S A (2000) 1.32

A small domain of CBP/p300 binds diverse proteins: solution structure and functional studies. Mol Cell (2001) 1.32

Personal debt and suicidal ideation. Psychol Med (2010) 1.32

Blood dyscrasias induced by psychotropic drugs. Pharmacopsychiatry (2004) 1.31

NMR investigations of the dynamics of the aromatic amino acid residues in the basic pancreatic trypsin inhibitor. FEBS Lett (1975) 1.30

Dimerization of the UmuD' protein in solution and its implications for regulation of SOS mutagenesis. Nat Struct Biol (1997) 1.30

Frequency spectrum of NH bonds in eglin c from spectral density mapping at multiple fields. Biochemistry (1995) 1.29

Amide proton exchange in proteins by EX1 kinetics: studies of the basic pancreatic trypsin inhibitor at variable p2H and temperature. Biochemistry (1985) 1.28

The interaction of eIF4E with 4E-BP1 is an induced fit to a completely disordered protein. Protein Sci (1998) 1.27

Generation of an LFA-1 antagonist by the transfer of the ICAM-1 immunoregulatory epitope to a small molecule. Science (2002) 1.27

Nuclear magnetic resonance of labile protons in the basic pancreatic trypsin inhibitor. J Mol Biol (1979) 1.25

Epidemiology of erectile dysfunction. Int J Impot Res (2003) 1.25

Solution structure of DFF40 and DFF45 N-terminal domain complex and mutual chaperone activity of DFF40 and DFF45. Proc Natl Acad Sci U S A (2001) 1.25

Comparison of four methods of heterochromatic photometry. J Opt Soc Am (1972) 1.24

Conformation of [Cd7]-metallothionein-2 from rat liver in aqueous solution determined by nuclear magnetic resonance spectroscopy. J Mol Biol (1988) 1.24

Increased sensitivity in HNCA and HN(CO)CA experiments by selective C beta decoupling. J Magn Reson B (1996) 1.23

A comparison of the Barthel Index and the OPCS disability instrument used to measure outcome after acute stroke. Age Ageing (1995) 1.22

The structural role of sugars in glycoproteins. Curr Opin Biotechnol (1996) 1.21